170 related articles for article (PubMed ID: 15105440)
1. Human loss-of-function gonadotropin-releasing hormone receptor mutants retain wild-type receptors in the endoplasmic reticulum: molecular basis of the dominant-negative effect.
Brothers SP; Cornea A; Janovick JA; Conn PM
Mol Endocrinol; 2004 Jul; 18(7):1787-97. PubMed ID: 15105440
[TBL] [Abstract][Full Text] [Related]
2. Dominant-negative action of disease-causing gonadotropin-releasing hormone receptor (GnRHR) mutants: a trait that potentially coevolved with decreased plasma membrane expression of GnRHR in humans.
Leaños-Miranda A; Ulloa-Aguirre A; Ji TH; Janovick JA; Conn PM
J Clin Endocrinol Metab; 2003 Jul; 88(7):3360-7. PubMed ID: 12843188
[TBL] [Abstract][Full Text] [Related]
3. Evolved regulation of gonadotropin-releasing hormone receptor cell surface expression.
Janovick JA; Ulloa-Aguirre A; Conn PM
Endocrine; 2003 Dec; 22(3):317-27. PubMed ID: 14709805
[TBL] [Abstract][Full Text] [Related]
4. Receptor-misrouting: an unexpectedly prevalent and rescuable etiology in gonadotropin-releasing hormone receptor-mediated hypogonadotropic hypogonadism.
Leaños-Miranda A; Janovick JA; Conn PM
J Clin Endocrinol Metab; 2002 Oct; 87(10):4825-8. PubMed ID: 12364481
[TBL] [Abstract][Full Text] [Related]
5. Rescue of hypogonadotropic hypogonadism-causing and manufactured GnRH receptor mutants by a specific protein-folding template: misrouted proteins as a novel disease etiology and therapeutic target.
Janovick JA; Maya-Nunez G; Conn PM
J Clin Endocrinol Metab; 2002 Jul; 87(7):3255-62. PubMed ID: 12107234
[TBL] [Abstract][Full Text] [Related]
6. Parallel regulation of membrane trafficking and dominant-negative effects by misrouted gonadotropin-releasing hormone receptor mutants.
Knollman PE; Janovick JA; Brothers SP; Conn PM
J Biol Chem; 2005 Jul; 280(26):24506-14. PubMed ID: 15886197
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relations of successful pharmacologic chaperones for rescue of naturally occurring and manufactured mutants of the gonadotropin-releasing hormone receptor.
Janovick JA; Goulet M; Bush E; Greer J; Wettlaufer DG; Conn PM
J Pharmacol Exp Ther; 2003 May; 305(2):608-14. PubMed ID: 12606630
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis of hypogonadotropic hypogonadism: restoration of mutant (E(90)K) GnRH receptor function by a deletion at a distant site.
Maya-Núñez G; Janovick JA; Ulloa-Aguirre A; Söderlund D; Conn PM; Méndez JP
J Clin Endocrinol Metab; 2002 May; 87(5):2144-9. PubMed ID: 11994356
[TBL] [Abstract][Full Text] [Related]
9. Intracellular gonadotropin-releasing hormone receptors in breast cancer and gonadotrope lineage cells.
Sedgley KR; Finch AR; Caunt CJ; McArdle CA
J Endocrinol; 2006 Dec; 191(3):625-36. PubMed ID: 17170220
[TBL] [Abstract][Full Text] [Related]
10. Plasma membrane expression of gonadotropin-releasing hormone receptors: regulation by peptide and nonpeptide antagonists.
Finch AR; Caunt CJ; Armstrong SP; McArdle CA
Mol Endocrinol; 2010 Feb; 24(2):423-35. PubMed ID: 20009083
[TBL] [Abstract][Full Text] [Related]
11. Refolding of misfolded mutant GPCR: post-translational pharmacoperone action in vitro.
Janovick JA; Brothers SP; Cornea A; Bush E; Goulet MT; Ashton WT; Sauer DR; Haviv F; Greer J; Conn PM
Mol Cell Endocrinol; 2007 Jun; 272(1-2):77-85. PubMed ID: 17555869
[TBL] [Abstract][Full Text] [Related]
12. Regulation of G protein-coupled receptor trafficking by inefficient plasma membrane expression: molecular basis of an evolved strategy.
Janovick JA; Knollman PE; Brothers SP; Ayala-Yáñez R; Aziz AS; Conn PM
J Biol Chem; 2006 Mar; 281(13):8417-25. PubMed ID: 16446355
[TBL] [Abstract][Full Text] [Related]
13. Use of pharmacoperones to reveal GPCR structural changes associated with constitutive activation and trafficking.
Janovick JA; Conn PM
Methods Enzymol; 2010; 485():277-92. PubMed ID: 21050923
[TBL] [Abstract][Full Text] [Related]
14. Rescue of misrouted GnRHR mutants reveals its constitutive activity.
Janovick JA; Pogozheva ID; Mosberg HI; Cornea A; Conn PM
Mol Endocrinol; 2012 Jul; 26(7):1179-88. PubMed ID: 22595961
[TBL] [Abstract][Full Text] [Related]
15. Agonist-induced internalization and downregulation of gonadotropin-releasing hormone receptors.
Finch AR; Caunt CJ; Armstrong SP; McArdle CA
Am J Physiol Cell Physiol; 2009 Sep; 297(3):C591-600. PubMed ID: 19587220
[TBL] [Abstract][Full Text] [Related]
16. Calnexin regulated gonadotropin-releasing hormone receptor plasma membrane expression.
Brothers SP; Janovick JA; Conn PM
J Mol Endocrinol; 2006 Dec; 37(3):479-88. PubMed ID: 17170088
[TBL] [Abstract][Full Text] [Related]
17. Four naturally occurring mutations in the human GnRH receptor affect ligand binding and receptor function.
Bédécarrats GY; Linher KD; Janovick JA; Beranova M; Kada F; Seminara SB; Michael Conn P; Kaiser UB
Mol Cell Endocrinol; 2003 Jul; 205(1-2):51-64. PubMed ID: 12890567
[TBL] [Abstract][Full Text] [Related]
18. Mice harboring Gnrhr E90K, a mutation that causes protein misfolding and hypogonadotropic hypogonadism in humans, exhibit testis size reduction and ovulation failure.
Stewart MD; Deng JM; Stewart CA; Mullen RD; Wang Y; Lopez S; Serna MK; Huang CC; Janovick JA; Pask AJ; Schwartz RJ; Conn PM; Behringer RR
Mol Endocrinol; 2012 Nov; 26(11):1847-56. PubMed ID: 22918878
[TBL] [Abstract][Full Text] [Related]
19. In vitro coexpression and pharmacological rescue of mutant gonadotropin-releasing hormone receptors causing hypogonadotropic hypogonadism in humans expressing compound heterozygous alleles.
Leaños-Miranda A; Ulloa-Aguirre A; Janovick JA; Conn PM
J Clin Endocrinol Metab; 2005 May; 90(5):3001-8. PubMed ID: 15728205
[TBL] [Abstract][Full Text] [Related]
20. Participation of the endoplasmic reticulum protein chaperone thio-oxidoreductase in gonadotropin-releasing hormone receptor expression at the plasma membrane.
Lucca-Junior W; Janovick JA; Conn PM
Braz J Med Biol Res; 2009 Feb; 42(2):164-7. PubMed ID: 19274343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
